Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Mar;40(3):727–733. doi: 10.1128/aac.40.3.727

Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium.

L C Chio 1, L A Bolyard 1, M Nasr 1, S F Queener 1
PMCID: PMC163188  PMID: 8851601

Abstract

Sulfanilanilides with 3',5'-halogen substitutions had Ki values 6- to 57-fold lower than the Ki of sulfamethoxazole when tested against dihydropteroate synthase from Toxoplasma gondii. The compounds acted as competitive inhibitors. These compounds were also active against dihydropteroate synthase from Pneumocystis carinii, Mycobacterium avium, and Escherichia coli but were not significantly more active than sulfamethoxazole. The compounds were significantly more active in culture than were standard agents. Against T. gondii in culture, 50% inhibitory concentrations were 7- to 30-fold lower than that of sulfadiazine; against P. carinii in culture, a concentration of 100 microM caused 33 to 95% inhibition of growth, compared with 9% inhibition with 100 microM sulfamethoxazole.

Full Text

The Full Text of this article is available as a PDF (249.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allegra C. J., Boarman D., Kovacs J. A., Morrison P., Beaver J., Chabner B. A., Masur H. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase. J Clin Invest. 1990 Feb;85(2):371–379. doi: 10.1172/JCI114448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atzori C., Bruno A., Chichino G., Bombardelli E., Scaglia M., Ghione M. Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii. Antimicrob Agents Chemother. 1993 Jul;37(7):1492–1496. doi: 10.1128/aac.37.7.1492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bartlett M. S., Edlind T. D., Durkin M. M., Shaw M. M., Queener S. F., Smith J. W. Antimicrotubule benzimidazoles inhibit in vitro growth of Pneumocystis carinii. Antimicrob Agents Chemother. 1992 Apr;36(4):779–782. doi: 10.1128/aac.36.4.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bartlett M. S., Fishman J. A., Durkin M. M., Queener S. F., Smith J. W. Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.). Exp Parasitol. 1990 Jan;70(1):100–106. doi: 10.1016/0014-4894(90)90089-u. [DOI] [PubMed] [Google Scholar]
  5. Bartlett M. S., Queener S. F., Shaw M. M., Richardson J. D., Smith J. W. Pneumocystis carinii is resistant to imidazole antifungal agents. Antimicrob Agents Chemother. 1994 Aug;38(8):1859–1861. doi: 10.1128/aac.38.8.1859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Broughton M. C., Queener S. F. Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs. Antimicrob Agents Chemother. 1991 Jul;35(7):1348–1355. doi: 10.1128/aac.35.7.1348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chio L. C., Queener S. F. Identification of highly potent and selective inhibitors of Toxoplasma gondii dihydrofolate reductase. Antimicrob Agents Chemother. 1993 Sep;37(9):1914–1923. doi: 10.1128/aac.37.9.1914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Durkin M. M., Bartlett M. S., Queener S. F., Shaw M. M., Lee C. H., Smith J. W. An enzyme-linked immunosorbent assay for enumeration of Pneumocystis carinii in vitro and in vivo. J Clin Microbiol. 1992 Dec;30(12):3258–3262. doi: 10.1128/jcm.30.12.3258-3262.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Eagon R. G., McManus A. T. Phosphanilic acid inhibits dihydropteroate synthase. Antimicrob Agents Chemother. 1989 Nov;33(11):1936–1938. doi: 10.1128/aac.33.11.1936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fishman J. A., Queener S. F., Roth R. S., Bartlett M. S. Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model. Antimicrob Agents Chemother. 1993 Jul;37(7):1543–1546. doi: 10.1128/aac.37.7.1543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hong Y. L., Hossler P. A., Calhoun D. H., Meshnick S. R. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. Antimicrob Agents Chemother. 1995 Aug;39(8):1756–1763. doi: 10.1128/aac.39.8.1756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lever O. W., Jr, Bell L. N., McGuire H. M., Ferone R. Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines. J Med Chem. 1985 Dec;28(12):1870–1874. doi: 10.1021/jm00150a019. [DOI] [PubMed] [Google Scholar]
  13. Merali S., Meshnick S. R. Susceptibility of Pneumocystis carinii to artemisinin in vitro. Antimicrob Agents Chemother. 1991 Jun;35(6):1225–1227. doi: 10.1128/aac.35.6.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Merali S., Zhang Y., Sloan D., Meshnick S. Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. Antimicrob Agents Chemother. 1990 Jun;34(6):1075–1078. doi: 10.1128/aac.34.6.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nasr M., Paull K. D., Narayanan V. L. Computer-assisted structure-activity correlations. Adv Pharmacol Chemother. 1984;20:123–190. doi: 10.1016/s1054-3589(08)60266-5. [DOI] [PubMed] [Google Scholar]
  16. Queener S. F., Bartlett M. S., Nasr M., Smith J. W. 8-aminoquinolines effective against Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother. 1993 Oct;37(10):2166–2172. doi: 10.1128/aac.37.10.2166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Queener S. F., Bartlett M. S., Richardson J. D., Durkin M. M., Jay M. A., Smith J. W. Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother. 1988 Jun;32(6):807–813. doi: 10.1128/aac.32.6.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Queener S. F., Fujioka H., Nishiyama Y., Furukawa H., Bartlett M. S., Smith J. W. In vitro activities of acridone alkaloids against Pneumocystis carinii. Antimicrob Agents Chemother. 1991 Feb;35(2):377–379. doi: 10.1128/aac.35.2.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rosowsky A., Freisheim J. H., Hynes J. B., Queener S. F., Bartlett M., Smith J. W., Lazarus H., Modest E. J. Tricyclic 2,4-diaminopyrimidines with broad antifolate activity and the ability to inhibit Pneumocystis carinii growth in cultured human lung fibroblasts in the presence of leucovorin. Biochem Pharmacol. 1989 Aug 15;38(16):2677–2684. doi: 10.1016/0006-2952(89)90554-6. [DOI] [PubMed] [Google Scholar]
  20. Voeller D., Kovacs J., Andrawis V., Chu E., Masur H., Allegra C. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone). J Infect Dis. 1994 Feb;169(2):456–459. doi: 10.1093/infdis/169.2.456. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES